Exelixis Inc Tax Withholding Paid on Stock Awards
Exelixis Inc (EXEL) reported Tax Withholding Paid on Stock Awards of $70.57 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- Exelixis Inc payment, tax withholding, share-based payment arrangement for the quarter ending 2026-07-03 was $36.34M, a 10.27% decline year-over-year.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for the quarter ending 2026-04-03 was $34.23M, a 52.03% increase year-over-year.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for the quarter ending 2026-01-02 was $4.83M, a 70.66% decline year-over-year.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for the quarter ending 2025-10-03 was $3.38M, a 55.91% increase year-over-year.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for fiscal 2026 was $71.22M, a 84.39% increase from fiscal 2025.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for fiscal 2025 was $38.63M, a 32.63% increase from fiscal 2023.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for fiscal 2023 was $29.12M, a 24.99% increase from fiscal 2022.
- Exelixis Inc payment, tax withholding, share-based payment arrangement for fiscal 2022 was $23.30M, a 40.42% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-07-03 | $36.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $70.57M 10-Q · filed 2026-08-05 | $75.40M derived: sum of 3 quarters · filed 2026-08-05 | $78.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-04-03 | $34.23M 10-Q · filed 2026-05-05 | $39.06M derived: sum of 2 quarters · filed 2026-05-05 | $42.43M derived: sum of 3 quarters · filed 2026-05-05 | $82.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-01-02 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $8.20M derived: sum of 2 quarters · filed 2026-02-10 | $48.70M derived: sum of 3 quarters · filed 2026-08-05 | $71.22M 10-K · filed 2026-02-10 |
| 2025-10-03 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $43.88M derived: sum of 2 quarters · filed 2026-08-05 | $66.39M 10-Q · filed 2025-11-04 | $82.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-07-04 | $40.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $63.02M 10-Q · filed 2026-08-05 | $79.46M derived: sum of 3 quarters · filed 2026-08-05 | $81.63M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-04-04 | $22.52M 10-Q · filed 2026-05-05 | $38.96M derived: sum of 2 quarters · filed 2026-05-05 | $41.13M derived: sum of 3 quarters · filed 2026-05-05 | $54.15M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-01-03 | $16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $18.61M derived: sum of 2 quarters · filed 2026-02-10 | $31.64M derived: sum of 3 quarters · filed 2026-02-10 | $38.63M 10-K · filed 2026-02-10 |
| 2024-09-27 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $15.19M derived: sum of 2 quarters · filed 2025-11-04 | $22.18M 10-Q · filed 2025-11-04 | $28.17M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-28 | $13.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28 | $20.01M 10-Q · filed 2025-07-28 | $26.00M derived: sum of 3 quarters · filed 2026-02-10 | $35.75M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-29 | $6.99M 10-Q · filed 2025-05-13 | $12.97M derived: sum of 2 quarters · filed 2026-02-10 | $22.72M derived: sum of 3 quarters · filed 2026-02-10 | $33.55M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-29 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $15.73M derived: sum of 2 quarters · filed 2026-02-10 | $26.57M derived: sum of 3 quarters · filed 2026-02-10 | $29.12M 10-K · filed 2026-02-10 |
| 2023-09-29 | $9.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $20.58M derived: sum of 2 quarters · filed 2024-10-29 | $23.14M 10-Q · filed 2024-10-29 | $30.34M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $10.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $13.39M 10-Q · filed 2024-08-06 | $20.60M derived: sum of 3 quarters · filed 2025-02-11 | $25.52M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $2.56M 10-Q · filed 2024-04-30 | $9.77M derived: sum of 2 quarters · filed 2025-02-11 | $14.69M derived: sum of 3 quarters · filed 2025-02-11 | $21.17M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-30 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $12.14M derived: sum of 2 quarters · filed 2025-02-11 | $18.61M derived: sum of 3 quarters · filed 2025-02-11 | $23.30M 10-K · filed 2025-02-11 |
| 2022-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.40M derived: sum of 2 quarters · filed 2023-11-01 | $16.09M 10-Q · filed 2023-11-01 | $40.15M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-07-01 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $11.16M 10-Q · filed 2023-08-01 | $35.22M derived: sum of 3 quarters · filed 2024-02-06 | $40.86M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-04-01 | $4.69M 10-Q · filed 2023-05-09 | $28.75M derived: sum of 2 quarters · filed 2024-02-06 | $34.38M derived: sum of 3 quarters · filed 2024-02-06 | $38.35M derived: sum of 4 quarters · filed 2024-02-06 |
| 2021-12-31 | $24.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06 | $29.70M derived: sum of 2 quarters · filed 2024-02-06 | $33.67M derived: sum of 3 quarters · filed 2024-02-06 | $39.11M 10-K · filed 2024-02-06 |
| 2021-10-01 | $5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $9.61M derived: sum of 2 quarters · filed 2022-11-01 | $15.05M 10-Q · filed 2022-11-01 | $38.95M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-07-02 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $9.41M 10-Q · filed 2022-08-09 | $33.31M derived: sum of 3 quarters · filed 2023-02-07 | $38.49M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-04-02 | $5.44M 10-Q · filed 2022-05-10 | $29.34M derived: sum of 2 quarters · filed 2023-02-07 | $34.52M derived: sum of 3 quarters · filed 2023-02-07 | $53.67M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-01-01 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $29.08M derived: sum of 2 quarters · filed 2023-02-07 | $48.23M derived: sum of 3 quarters · filed 2023-02-07 | $50.02M 10-K · filed 2023-02-07 |
| 2020-10-02 | $5.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $24.33M derived: sum of 2 quarters · filed 2021-11-02 | $26.12M 10-Q · filed 2021-11-02 | $32.66M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-07-03 | $19.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $20.94M 10-Q · filed 2021-08-05 | $27.48M derived: sum of 3 quarters · filed 2022-02-18 | $28.41M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-04-03 | $1.79M 10-Q · filed 2021-05-06 | $8.33M derived: sum of 2 quarters · filed 2022-02-18 | $9.26M derived: sum of 3 quarters · filed 2022-02-18 | $10.12M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-01-03 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $7.47M derived: sum of 2 quarters · filed 2022-02-18 | $8.32M derived: sum of 3 quarters · filed 2022-02-18 | $9.90M 10-K · filed 2022-02-18 |
| 2019-09-27 | $935.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.79M derived: sum of 2 quarters · filed 2020-11-05 | $3.37M 10-Q · filed 2020-11-05 | $7.74M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-28 | $854.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.43M 10-Q · filed 2020-08-06 | $6.80M derived: sum of 3 quarters · filed 2020-08-06 | $7.03M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-29 | $1.58M 10-Q · filed 2020-05-05 | $5.95M derived: sum of 2 quarters · filed 2020-05-05 | $6.18M derived: sum of 3 quarters · filed 2020-05-05 | $7.03M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-28 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $4.60M derived: sum of 2 quarters · filed 2020-02-25 | $5.45M derived: sum of 3 quarters · filed 2020-02-25 | $7.57M 10-K · filed 2021-02-11 |
| 2018-09-28 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.08M derived: sum of 2 quarters · filed 2019-10-30 | $3.21M 10-Q · filed 2019-10-30 | $6.76M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-29 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $2.98M 10-Q · filed 2019-07-31 | $6.53M derived: sum of 3 quarters · filed 2020-02-25 | $7.21M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-30 | $2.13M 10-Q · filed 2019-05-01 | $5.68M derived: sum of 2 quarters · filed 2020-02-25 | $6.36M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-29 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $4.23M derived: sum of 2 quarters · filed 2020-02-25 | $6.56M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $3.01M 10-Q · filed 2017-11-01 | ||
| 2017-09-29 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.47M derived: sum of 2 quarters · filed 2018-11-01 | $3.01M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $788.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.33M 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | $1.54M 10-Q · filed 2017-05-01 | |||
| 2016-12-30 | $4.11M 10-K · filed 2019-02-22 | |||
| 2016-09-30 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $799.00K derived: sum of 2 quarters · filed 2017-11-01 | $2.71M 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $2.06M 10-Q · filed 2017-08-02 | ||
| 2016-03-31 | $1.91M 10-Q · filed 2017-05-01 | |||
| 2016-01-01 | $534.00K 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |